![Ingrid Delaet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ingrid Delaet
Conseiller Juridique Général chez
NEUROCRINE BIOSCIENCES, INC.
Fortune : 3 M $ au 31/08/2026
Profil
Dr. Ingrid Delaet is a Chief Regulatory Officer at Neurocrine Biosciences, Inc. Dr. Delaet was previously employed as a Senior Vice President-Regulatory Affairs by Intercept Pharmaceuticals, Inc., a Global Regulatory Affairs by Bristol Myers Squibb Co., a Head-Clinical Research by CellPro, Inc., and a Head-Clinical Research by Wyeth-Ayerst Research.
She received her graduate degree from Université Libre de Bruxelles and a doctorate degree from Université Libre de Bruxelles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/09/2026 | 18 289 ( 0,02% ) | 3 M $ | 31/08/2026 |
Postes actifs de Ingrid Delaet
| Sociétés | Poste | Début |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Conseiller Juridique Général | 01/01/2021 |
Anciens postes connus de Ingrid Delaet
| Sociétés | Poste | Fin |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Conseiller Juridique Général | 01/09/2016 |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
CellPro, Inc.
 CellPro, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Corporate Officer/Principal | - |
Formation de Ingrid Delaet
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
CellPro, Inc.
CellPro, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth-Ayerst Research |
